Combined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (live, Hangzhou Grand Biologic)
双歧杆菌四联活菌（杭州远大生物制药）
Report date: 2022/09/27 17:03:27
Base Information
Drug NameCombined Bifidobacterium ,Lactobacillus,Enterococcus And Bacillus (live, Hangzhou Grand Biologic)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2006/03/02
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGrand Pharmaceutical （China） Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChina Grand Pharmaceutical And Healthcare Holdings LtdHangzhou Longda Xinke Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A